OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
MIAMI, Jan. 09, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK) (the “Company”) today announced the closing of its previously announced private offering of $230.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “Notes”), which amount includes the full exercise of the initial purchaser’s option to purchase an additional $30.0 million aggregate principal amount of the Notes.
Related news for (OPK)
- OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
- OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
- OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
- OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
- OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
